| Identification | Back Directory | [Name]
Ronipamil | [CAS]
85247-77-4 | [Synonyms]
Ronipamil Ronipamilo Ronipamil USP/EP/BP α-Dodecyl-α-[3-[methyl(2-phenylethyl)amino]propyl]benzeneacetonitrile Benzeneacetonitrile, α-dodecyl-α-[3-[methyl(2-phenylethyl)amino]propyl]- | [Molecular Formula]
C32H48N2 | [MDL Number]
MFCD00868771 | [MOL File]
85247-77-4.mol | [Molecular Weight]
460.745 |
| Hazard Information | Back Directory | [Uses]
Ronipamil is a calcium ion antagonist. Ronipamil increases the specific binding and internalization of human 125I-LDL in human skin fibroblasts (HSF) and the human hepatoma cell line Hep G2[1]. | [References]
[1] Corsini A, et al. Calcium antagonists and low density lipoproteins metabolism by human fibroblasts and by human hepatoma cell line HEP G2[J]. Pharmacological research communications, 1986, 18(1): 1-16. DOI:10.1016/0031-6989(86)90155-4 |
|
| Company Name: |
Leancare Ltd.
|
| Tel: |
+33 962096793 |
| Website: |
www.leancare.co.uk |
|